Kawachi Pharmaceutical Reports Interim Operating Profit Down 6.2%
Consolidated operating profit for the September interim period was 30.09億円, down 6.2%. The forecast for the fiscal year ending March was 51.00億円, down 24.8%.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.